Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McDaniel, M. L.
Right arrow Articles by Kwon, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McDaniel, M. L.
Right arrow Articles by Kwon, G.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 51:2877-2885, 2002
© 2002 by the American Diabetes Association, Inc.


Perspectives in Diabetes

Metabolic and Autocrine Regulation of the Mammalian Target of Rapamycin by Pancreatic ß-Cells

Michael L. McDaniel, Connie A. Marshall, Kirk L. Pappan, and Guim Kwon

From the Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri

Mammalian target of rapamycin (mTOR) is a serine and threonine protein kinase that regulates numerous cellular functions, in particular, the initiation of protein translation. mTOR-mediated phosphorylation of both the translational repressor eukaryotic initiation factor 4E binding protein-1 and p70 S6 kinase are early events that control the translation initiation process. Rapamycin, an inhibitor of mTOR, is a potent immunosuppressant due, in part, to its ability to interfere with T-cell activation at the level of translation, and it has gained a prominent role in preventing the development and progression of rejection in pancreatic islet transplant recipients. The characterization of the insulin signaling cascade that modulates mTOR in insulin-sensitive tissues has been a major focus of investigation. Recently, the ability of nutrients, in particular the branched-chain amino acid leucine, to activate mTOR independent of insulin by a process designated as nutrient signaling has been identified. The ß-cell expresses components of the insulin signaling cascade and utilizes the metabolism of nutrients to affect insulin secretion. These combined transduction processes make the ß-cell an unique cell to study metabolic and autocrine regulation of mTOR signaling. Our studies have described the ability of insulin and IGFs in concert with the nutrients leucine, glutamine, and glucose to modulate protein translation through mTOR in ß-cells. These findings suggest that mitochondria-derived factors, ATP in particular, may be responsible for nutrient signaling. The significance of these findings is that the optimization of mitochondrial function is not only important for insulin secretion but may significantly impact the growth and proliferation of ß-cells through these mTOR signaling pathways.



Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
C. E. Gleason, D. Lu, L. A. Witters, C. B. Newgard, and M. J. Birnbaum
The Role of AMPK and mTOR in Nutrient Sensing in Pancreatic beta-Cells
J. Biol. Chem., April 6, 2007; 282(14): 10341 - 10351.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
E. Fernandez, M. A. Martin, S. Fajardo, F. Escriva, and C. Alvarez
Increased IRS-2 content and activation of IGF-I pathway contribute to enhance beta-cell mass in fetuses from undernourished pregnant rats
Am J Physiol Endocrinol Metab, January 1, 2007; 292(1): E187 - E195.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
P. Newsholme, L. Brennan, and K. Bender
Amino Acid Metabolism, {beta}-Cell Function, and Diabetes
Diabetes, December 1, 2006; 55(Supplement_2): S39 - S47.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. A. Martens, Q. Wang, K. Kerckhofs, G. Stange, Z. Ling, and D. Pipeleers
Metabolic Activation of Glucose Low-Responsive {beta}-Cells by Glyceraldehyde Correlates with Their Biosynthetic Activation in Lower Glucose Concentration Range But Not at High Glucose
Endocrinology, November 1, 2006; 147(11): 5196 - 5204.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Kwon, C. A. Marshall, H. Liu, K. L. Pappan, M. S. Remedi, and M. L. McDaniel
Glucose-stimulated DNA Synthesis through Mammalian Target of Rapamycin (mTOR) Is Regulated by KATP Channels: EFFECTS ON CELL CYCLE PROGRESSION IN RODENT ISLETS
J. Biol. Chem., February 10, 2006; 281(6): 3261 - 3267.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Briaud, L. M. Dickson, M. K. Lingohr, J. F. McCuaig, J. C. Lawrence, and C. J. Rhodes
Insulin Receptor Substrate-2 Proteasomal Degradation Mediated by a Mammalian Target of Rapamycin (mTOR)-induced Negative Feedback Down-regulates Protein Kinase B-mediated Signaling Pathway in {beta}-Cells
J. Biol. Chem., January 21, 2005; 280(3): 2282 - 2293.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
G. Kwon, C. A. Marshall, K. L. Pappan, M. S. Remedi, and M. L. McDaniel
Signaling Elements Involved in the Metabolic Regulation of mTOR by Nutrients, Incretins, and Growth Factors in Islets
Diabetes, December 1, 2004; 53(suppl_3): S225 - S232.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
L. M. Dickson and C. J. Rhodes
Pancreatic {beta}-cell growth and survival in the onset of type 2 diabetes: a role for protein kinase B in the Akt?
Am J Physiol Endocrinol Metab, August 1, 2004; 287(2): E192 - E198.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. Andreozzi, C. D'Alessandris, M. Federici, E. Laratta, S. Del Guerra, S. Del Prato, P. Marchetti, R. Lauro, F. Perticone, and G. Sesti
Activation of the Hexosamine Pathway Leads to Phosphorylation of Insulin Receptor Substrate-1 on Ser307 and Ser612 and Impairs the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Insulin Biosynthetic Pathway in RIN Pancreatic {beta}-Cells
Endocrinology, June 1, 2004; 145(6): 2845 - 2857.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. M. Drenan, X. Liu, P. G. Bertram, and X. F. S. Zheng
FKBP12-Rapamycin-associated Protein or Mammalian Target of Rapamycin (FRAP/mTOR) Localization in the Endoplasmic Reticulum and the Golgi Apparatus
J. Biol. Chem., January 2, 2004; 279(1): 772 - 778.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
T. E. Harris and J. C. Lawrence Jr.
TOR Signaling
Sci. Signal., December 9, 2003; 2003(212): re15 - re15.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Wicksteed, C. Alarcon, I. Briaud, M. K. Lingohr, and C. J. Rhodes
Glucose-induced Translational Control of Proinsulin Biosynthesis Is Proportional to Preproinsulin mRNA Levels in Islet {beta}-Cells but Not Regulated via a Positive Feedback of Secreted Insulin
J. Biol. Chem., October 24, 2003; 278(43): 42080 - 42090.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. J. Lynch, B. Halle, H. Fujii, T. C. Vary, R. Wallin, Z. Damuni, and S. M. Hutson
Potential role of leucine metabolism in the leucine-signaling pathway involving mTOR
Am J Physiol Endocrinol Metab, October 1, 2003; 285(4): E854 - E863.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2002 by the American Diabetes Association.